Rationale for Anti-angiogenic Therapy in Pheochromocytoma and Paraganglioma

Author： Favier Judith  

Publisher： Humana Press, Inc

ISSN： 1046-3976

Source： Endocrine Pathology, Vol.23, Iss.1, 2012-03, pp. : 34-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-angiogenic therapy: Rationale, challenges and clinical studies

By Longo R.   Sarmiento R.   Fanelli M.   Capaccetti B.   Gattuso D.   Gasparini G.  

Angiogenesis, Vol. 5, Iss. 4, 2002-01 ,pp. : 237-256

Springer Publishing Company

Access to resources Recommend Favorite

Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features

By Mazza Alberto   Armigliato Michela   Marzola Maria   Schiavon Laura   Montemurro Domenico   Vescovo Giorgio   Zuin Marco   Chondrogiannis Sotirios   Ravenni Roberta   Opocher Giuseppe   Colletti Patrick   Rubello Domenico  

Endocrine, Vol. 45, Iss. 3, 2014-04 ,pp. : 469-478

Springer Publishing Company

Access to resources Recommend Favorite

Multiple angiogenesis stimulators in a single malignancy: Implications for anti-angiogenic tumour therapy

By Pavlakovic H.  

Angiogenesis, Vol. 4, Iss. 4, 2001-01 ,pp. : 259-262

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy

By  

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 52-56

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis of silent pheochromocytoma and paraganglioma

By Clifton-Bligh Roderick  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 47-57

Informa Healthcare

Access to resources Recommend Favorite